NOTICE OF ALLOWANCE - ISSUED
issued
on 01 Oct 2024
Last Applicant/ Owned by
SUITE 1900
CINCINNATI
OH
45202
Serial Number
98267927 filed on 13th Nov 2023
Registration Number
N/A
Correspondent Address
Danielle Cohen, Esq.
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
ONCONETIX
Medical research services in personalized medicine, patient treatment, therapeutics and diagnostics Medical apparatus for personalized medical therapeutics, namely, infusion and injection devices for administering therapeutic drugs of various types, namely, small molecules, biopharmaceuticals, cellular therapies, gene therapies, vaccines, CRISPR-Cas9 derived, CAR T-Cell derived, N - 1 personalize Read More
Classification Information
Class [010]
Medical Instrument Products
Medical apparatus for personalized medical therapeutics, namely, infusion and injection devices for administering therapeutic drugs of various types, namely, small molecules, biopharmaceuticals, cellular therapies, gene therapies, vaccines, CRISPR-Cas9 derived, CAR T-Cell derived, N - 1 personalized drug therapies, Antibody-Drug-Conjugates (ADCs), Oncolytic viruses, monoclonal antibodies, bi-specific antibodies, virus-like particles-based therapeutics, and nano-encapsulated drug like synthetic therapeutics, into the human body utilizing both in-vivo and in-vitro, gene or cellular therapy methods
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [009]
Computer & Software Products & Electrical & Scientific Products
Downloadable medical computer software platforms containing diagnostic algorithms and decision-making computation to support screening, diagnosing, monitoring and treatment modalities of diseases; downloadable medical computer software platforms for aiding in decision-making in clinical and after-regulatory approval of therapeutics and diagnostics; downloadable medical computer software platforms for managing and maintaining pre-clinical trials, clinical trials and assessments of patient's tumors in their staging and treatment
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment of cancer featuring small molecules, biopharmaceuticals, Antibody-Drug-Conjugates (ADCs), Oncolytic viruses, virus-like particles-based therapeutics, and nano-encapsulated drug like synthetic therapeutics; Pharmaceutical preparations for the treatment of cancer for use in cellular therapies, gene therapies, N - 1 personalized drug therapies, and CAR T-cell therapy; Pharmaceutical preparations for the treatment of cancer derived from CRISPR-Cas9 and CAR T-Cell; Vaccine preparations; Antibodies for medical purposes, namely, monoclonal antibodies and bi-specific antibodies; Medical diagnostic reagents and diagnostic preparations for use in-vitro, in-vivo, cell-based assays, cell culture processes, laboratory-developed tests (LDTs), cell-based imagining, genomics, gene-based expression assays, proteomics, protein-based expression assays, immunohistochemistry (IHC), drug sensitivity and treatment diagnostics
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [044]
Medical, Beauty & Agricultural Services
Biobanking services, namely, human and animal organ and tissue bank services; Medical digital pathology services for diagnostic or treatment purposes of human and animal tumors; Medical imaging services for cellular systems for the characterization of human and animal tumors
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Medical research services in personalized medicine, patient treatment, therapeutics and diagnostics
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98267927
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 17974.036
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 01st Oct 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 06th Aug 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 06th Aug 2024 | PUBLISHED FOR OPPOSITION |
| 17th Jul 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 01st Jul 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 28th Jun 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 28th Jun 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 28th Jun 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 24th Jun 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 24th Jun 2024 | NON-FINAL ACTION WRITTEN |